141.645  2.665 (1.92%)		10-29 15:10
Open: 140.1 High: 142.045 Volume: 371,097		Pre. Close: 138.98 Low: 139.215 Market Cap: 6,002(M)

Short term
Mid term
Targets	6-month :	165.37	1-year :	193.16
Resists	First :	141.58	Second :	165.37
Pivot price	131.82
Supports	First :	127.2	Second :	118.3
MAs	MA(5) :	138.47	MA(20) :	130
	MA(100) :	131.73	MA(250) :	123.01
MACD	MACD :	2.9	Signal :	1.3
%K %D	K(14,3) :	97.3	D(3) :	95.9
RSI	RSI(14): 73
52-week	High :	144.64	Low :	99.38

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ TFX ] has closed below upper band by 8.6%. Bollinger Bands are 87.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	140.17 - 140.91	140.91 - 141.54
Low:	135.17 - 136.01	136.01 - 136.72
Close:	137.59 - 139.03	139.03 - 140.24

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

Thu, 29 Oct 2026
Teleflex Incorporated (TFX) Stock Forecasts - Yahoo Finance

Wed, 28 Oct 2026
Teleflex Incorporated (TFX) Latest Stock News & Headlines - Yahoo Finance

Tue, 27 Oct 2026
Teleflex Incorporated (TFX) stock price, news, quote and history - Yahoo Finance Singapore

Tue, 27 Oct 2026
FDA Device Breakthrough Might Change The Case For Investing In Teleflex Stock (TFX) - Yahoo Finance Singapore

Thu, 22 Oct 2026
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information - Yahoo Finance

Thu, 22 Oct 2026
Teleflex Incorporated $TFX Shares Sold by State of Alaska Department of Revenue - MarketBeat

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	42 (M)
Shares Float	42 (M)
Held by Insiders	0.6 (%)
Held by Institutions	114.9 (%)
Shares Short	4,050 (K)
Shares Short P.Month	4,020 (K)

EPS	-8.48
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	68.55
Profit Margin	-45.8 %
Operating Margin	10 %
Return on Assets (ttm)	1.7 %
Return on Equity (ttm)	-0.7 %
Qtrly Rev. Growth	28.8 %
Gross Profit (p.s.)	29.26
Sales Per Share	53.1
EBITDA (p.s.)	9.53
Qtrly Earnings Growth	-17.3 %
Operating Cash Flow	403 (M)
Levered Free Cash Flow	180 (M)

PE Ratio	-16.67
PEG Ratio	0.1
Price to Book value	2.06
Price to Sales	2.66
Price to Cash Flow	14.85

Dividend	0.34
Forward Dividend	0
Dividend Yield	0.2%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.